LOMITAPIDE (Lojuxta®)
Clinical Indication
Homozygous familial hypercholesterolaemia
Comments
Requested for UHL as part of NHS England commissioning policy.
Date of classification
September 2018
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.